Aspen Grove Capital’s Baxter International BAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Sell
11,728
-31
-0.3% -$578 0.04% 187
2026
Q1
$198K Hold
11,759
– – 0.04% 190
2025
Q4
$225K Buy
11,759
+700
+6% +$14K 0.04% 180
2025
Q3
$254K Sell
11,059
-636
-5% -$16.1K 0.04% 166
2025
Q2
$356K Sell
11,695
-27
-0.2% -$819 0.06% 142
2025
Q1
$403K Buy
11,722
+320
+3% +$10.5K 0.08% 131
2024
Q4
$334K Sell
11,402
-711
-6% -$23.9K 0.07% 135
2024
Q3
$464K Buy
12,113
+43
+0.4% +$1.58K 0.1% 108
2024
Q2
$408K Sell
12,070
-616
-5% -$22.7K 0.1% 120
2024
Q1
$549K Sell
12,686
-9,430
-43% -$383K 0.16% 86
2023
Q4
$861K Buy
22,116
+313
+1% +$11.1K 0.26% 67
2023
Q3
$832K Sell
21,803
-7,988
-27% -$340K 0.31% 59
2023
Q2
$1.37M Buy
29,791
+204
+0.7% +$8.88K 0.44% 53
2023
Q1
$1.21M Buy
29,587
+392
+1% +$16.6K 0.53% 45
2022
Q4
$1.5M Buy
+29,195
New +$1.57M 0.69% 36

Other funds holding BAX

Aspen Grove Capital's BAX Position: Q2 2026 in Review

Aspen Grove Capital reduced its Baxter International (BAX) stake by 0.26% in Q2 2026, selling an estimated $578 and leaving 11,728 shares worth $250K. The position accounts for 0.04% of the portfolio, ranked #187.

Aspen Grove Capital first reported a position in BAX in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.5M in Q4 2022. 687 funds tracked by Wall St. Rank hold BAX as of Q2 2026.

  • Aspen Grove Capital held 11,728 shares of Baxter International worth $250K as of Q2 2026.
  • Aspen Grove Capital sold 31 Baxter International shares in Q2 2026, an estimated $578.
  • Baxter International made up 0.04% of Aspen Grove Capital's portfolio in Q2 2026, its #187 holding.
  • Aspen Grove Capital first reported a position in Baxter International in Q4 2022 and has held it in 15 quarters since.
  • Aspen Grove Capital's Baxter International position peaked at $1.5M in Q4 2022.
  • 687 funds tracked by Wall St. Rank held Baxter International as of Q2 2026.

Based on Aspen Grove Capital's 13F filing for Q2 2026, filed 14 Aug 2026.